Um dos principais objetivos do Life4me+ - é prevenir novos casos de HIV e outras ISTs, hepatite C e tuberculose.

O aplicativo ajuda a estabelecer uma comunicação anônima entre médicos e pessoas soropositivas. A App permite que você organize convenientemente o seu horário de toma dos medicamentos e defina de uma forma personalizada os lembretes.

Voltar
29 abril 2022, 13:56
2155

Theratechnologies pulls of out Europe, taking ibalizumab with it

Theratechnologies pulls of out Europe, taking ibalizumab with it - foto 1

Biotech company Theratechnologies, which develops innovative therapies, has announced that it is withdrawing from the European market and will now focus its activities solely in North America. Accordingly, the company will be ceasing the sale of their monoclonal antibody based HIV treatment ibalizumab (trade name Trogarzo) in Europe.

The company stated that the rationale behind their actions was financial, saying that pricing conditions and reimbursement of the drug “did not satisfy Theratechnologies”.

"Although Trogarzo is an important and effective means of treating people living with HIV, further commercial sale of the drug at the proposed prices and conditions of reimbursement by European governments would lead to constant losses for Theratetechnologies," the statement reads.

The company stated that it intends to comply with regulatory obligations towards European patients “for the necessary period of time”.

Autor: Tom Hayes
Tradutor: Tom Hayes

Compartilhar nas redes sociais